Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhen-Qi-Jie-Du Granules is an investigational traditional Chinese medicine (TCM) compound formulation being developed by Jiangsu Famous Medical Technology in collaboration with the Jiangsu Collaborative Innovation Center for Traditional Chinese Medicine Cancer Prevention and Treatment. It is designed as an adjuvant therapy for patients with advanced, unresectable stage IV microsatellite-stable (MSS) colorectal cancer. Administered orally as granules, the formula is evaluated in combination with standard chemotherapy regimens to assess its synergistic effects in prolonging progression-free survival, improving disease control, and alleviating cancer-related fatigue and chemotherapy-induced myelosuppression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhen-Qi-Jie-Du Granules.